Africa’s largest pharmaceuticals group Aspen is also in the running to take over parts of the former Organon operation in Oss, the Financieele Dagblad reports on Wednesday.

The paper bases its claims on sources close to talks on the future of the research and development unit.
Parent company Merck plans to close down the R&D department and one production line with the loss of over 2,000 jobs.
Aspen is a major producer of generic medicines but is being forced by competition from China and India to look for more innovative products, a source told the paper.
Japan’s Takema Pharmaceuticals and Dutch biotech firm Pantarhei have been cited as possible new owners.
Workers are expected to be told about their future later on Wednesday morning, the paper says.